>
Switch to:

National Research Sloan Ratio %

: 2.20% (As of Mar. 2022)
View and export this data going back to 1997. Start your Free Trial

Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.

National Research's Sloan Ratio for the quarter that ended in Mar. 2022 was 2.20%.

As of Mar. 2022, National Research has a Sloan Ratio of 2.20%, indicating the company is in the safe zone and there is no funny business with accruals.


National Research Sloan Ratio % Historical Data

The historical data trend for National Research's Sloan Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

National Research Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Sloan Ratio %
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.76 -3.55 -3.48 0.26 -0.23

National Research Quarterly Data
Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22
Sloan Ratio % Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.05 -5.42 -3.90 -0.23 2.20

Competitive Comparison

For the Health Information Services subindustry, National Research's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

National Research Sloan Ratio % Distribution

For the Healthcare Providers & Services industry and Healthcare sector, National Research's Sloan Ratio % distribution charts can be found below:

* The bar in red indicates where National Research's Sloan Ratio % falls into.



National Research Sloan Ratio % Calculation

Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.

National Research's Sloan Ratio for the fiscal year that ended in Dec. 2021 is calculated as

Sloan Ratio=(Net Income (A: Dec. 2021 )-Cash Flow from Operations (A: Dec. 2021 )
-Cash Flow from Investing (A: Dec. 2021 ))/Total Assets (A: Dec. 2021 )
=(37.466-46.344
--8.514)/157.54
=-0.23%

National Research's Sloan Ratio for the quarter that ended in Mar. 2022 is calculated as

Sloan Ratio=(Net Income (TTM)-Cash Flow from Operations (TTM})
-Cash Flow from Investing (TTM))/Total Assets (Q: Mar. 2022 )
=(36.773-40.226
--6.818)/153.154
=2.20%

National Research's Net Income for the trailing twelve months (TTM) ended in Mar. 2022 was 8.944 (Jun. 2021 ) + 9.657 (Sep. 2021 ) + 9.633 (Dec. 2021 ) + 8.539 (Mar. 2022 ) = $36.8 Mil.
National Research's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2022 was 11.158 (Jun. 2021 ) + 8.704 (Sep. 2021 ) + 12.074 (Dec. 2021 ) + 8.29 (Mar. 2022 ) = $40.2 Mil.
National Research's Cash Flow from Investing for the trailing twelve months (TTM) ended in Mar. 2022 was -1.567 (Jun. 2021 ) + -0.992 (Sep. 2021 ) + -1.717 (Dec. 2021 ) + -2.542 (Mar. 2022 ) = $-6.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


National Research  (NAS:NRC) Sloan Ratio % Explanation

A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.

According to How to Beat the Market with the Sloan Ratio:

If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.

If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.

If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.

As of Mar. 2022, National Research has a Sloan Ratio of 2.20%, indicating the company is in the safe zone and there is no funny business with accruals.


National Research Sloan Ratio % Related Terms

Thank you for viewing the detailed overview of National Research's Sloan Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


National Research Business Description

National Research logo
Industry
Traded in Other Exchanges
Address
1245 Q Street, Lincoln, NE, USA, 68508
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. The solutions are offered at an enterprise level through the Voice of the Customer platform, The Governance Institute, and legacy Experience solutions. It operates in the US and Canada, of which key revenue is derived from the US.
Executives
Jackson Steven D. officer: President C/O NATIONAL RESEARCH CORPORATION 1245 Q STREET LINCOLN NE 68508
Martin Joann M director 6221 ANDREW COURT LINCOLN NE 68512
Nunnelly John N director P.O. BOX 2175 AMHERST MA 01004
Karas Kevin R officer: SVP Finance, CFO, Treas & Secy C/O NATIONAL RESEARCH CORPORATION 1245 Q STREET LINCOLN NE 68508
Berwick Donald M director C/O NATIONAL RESEARCH CORPORATION 1245 Q STREET LINCOLN NE 68508
Mowry Barbara director P.O. BOX 103115 DENVER CO 80250
Amandla Mk Trust 10 percent owner C/O THE BRYN MAWR TRUST COMPANY OF DELAW 20 MONTCHANIN RD, SUITE 100 GREENVILLE DE 19807
Hays Michael D. director, officer: CEO C/O NATIONAL RESEARCH CORPORATION 1245 Q STREET LINCOLN NE 68508
K/i/e Trust Under Agreement 10/24/18 10 percent owner C/O BESSEMER TRUST COMPANY OF DELAWARE 1007 N. ORANGE ST., SUITE 1450 WILMINGTON DE 19801
Endacott Kent E. 10 percent owner C/O WOODS & AITKEN LLP 301 SOUTH 13TH STREET, SUITE 500 LINCOLN NE 68508
Beans Patrick E director, officer: CFO and Secretary AMANDLA LLC 709 PIER 2 LINCOLN NE 68528
Warden Gail L director 250 WASHINGTON RD GROSSE POINTE MI 48230
Henricks Susan L officer: President and COO C/O NATIONAL RESEARCH CORPORATION 1245 Q STREET LINCOLN NE 68508
Schorr Paul C Iii director PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"> Ownership Information: SCHORR PAUL C III a.header:link {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:visited {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:hover {color: #191970;}
Peetz Jeffery T 10 percent owner WOODS & AITKEN LLP 301 SOUTH 13TH STREET, SUITE 500 LINCOLN NE 68508
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)